BiotechTube

Lunesta + Placebo control

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
85
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Obstructive Sleep Apnea

Conditions

Obstructive Sleep Apnea

Trial Timeline

Mar 1, 2007 โ†’ Oct 1, 2007

NCT ID
NCT00507117

About Lunesta + Placebo control

Lunesta + Placebo control is a approved stage product being developed by Sumitomo Pharma for Obstructive Sleep Apnea. The current trial status is completed. This product is registered under clinical trial identifier NCT00507117. Target conditions include Obstructive Sleep Apnea.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00507117ApprovedCompleted

Competing Products

20 competing products in Obstructive Sleep Apnea

See all competitors
ProductCompanyStageHype Score
Daridorexant + PlaceboIdorsiaPhase 1
28
Mavacamten + PlaceboLianBioPhase 3
69
CT-G20 + PlaceboCelltrionPhase 1
33
Reldesemtiv + PlaceboAstellas PharmaPhase 2
52
Placebo + Lemborexant 10 mg + Lemborexant 25 mg + Placebo + Lemborexant 10 mgEisaiPhase 1
33
lysozyme 90 mg + PlaceboEisaiApproved
85
Placebo + Lemborexant 10 mg + Placebo + Lemborexant 10 mgEisaiPhase 1
33
Eloralintide + PlaceboEli LillyPhase 3
77
Tirzepatide + PlaceboEli LillyPhase 3
77
Arformoterol tartrate inhalation solution + Arformoterol 25 ลณg BID + Formoterol 12 ลณg BID + PlaceboSumitomo PharmaPhase 3
77
arformoterol tartrate inhalation solution + arformoterol tartrate inhalation solution + arformoterol tartrate inhalation solution + Salmeterol + PlaceboSumitomo PharmaPhase 3
77
arformoterol + salmeterolSumitomo PharmaPre-clinical
23
Eszopiclone + PlaceboSumitomo PharmaPhase 2
52
Arformoterol + PlaceboSumitomo PharmaPhase 3
77
Eszopiclone + Placebo controlSumitomo PharmaApproved
85
Eszopiclone + PlaceboSumitomo PharmaPhase 1
33
Arformoterol tartrate + Placebo: Normal SalineSumitomo PharmaApproved
85
Arformoterol tartrate inhalation solution + TiotropiumSumitomo PharmaApproved
85
Nebulized arformoterol + SalmeterolSumitomo PharmaApproved
85
Arformoterol Tartrate Inhalation Solution + Arformoterol Tartrate Inhalation Solution + PlaceboSumitomo PharmaApproved
85

Other Products from Sumitomo Pharma

BlonanserinApproved
85
Mosapride + domperidoneApproved
85
levalbuterol HCl + albuterol SulfateApproved
85
LurasidoneApproved
85
placebo, isotonic ciclesonide, hypotonic ciclesonideApproved
85